Genotype Diagnostics

Conditions Genes Testing Resources

Home >  Conditions > 

Bookmark and Share Bookmark & Share

Adenosine monophosphate deaminase deficiency


  • AMP deaminase deficiency
  • Exercise-induced myopathy
  • MADA deficiency
  • MAD deficiency
  • Myoadenylate deaminase deficiency


  • Adenosine monophosphate (AMP) deaminase deficiency is a condition that can affect the muscles used for movement (skeletal muscles). People with this condition do not make enough of an enzyme called AMP deaminase. In most people, AMP deaminase deficiency does not cause any symptoms. People who do experience symptoms typically have muscle pain (myalgia) or weakness after exercise or prolonged physical activity. They often get tired more quickly and stay tired longer than would normally be expected. Some affected individuals have more severe symptoms, but it is unclear whether these symptoms are due solely to a lack of AMP deaminase or additional factors. Muscle weakness is typically apparent beginning in childhood or early adulthood.

    Researchers have proposed three types of AMP deaminase deficiency, which are distinguished by their symptoms and genetic cause..


    Frequency:  

    AMP deaminase deficiency is one of the most common inherited muscle disorders in Caucasians, affecting 1 in 50 to 100 people. The prevalence is lower in African-Americans, affecting an estimated 1 in 40,000 people, and the condition is even less common in the Japanese population.


    Related Genes:  

    Mutations in the AMPD1 gene cause AMP deaminase deficiency. The AMPD1 gene provides instructions for producing an enzyme called AMP deaminase. This enzyme is found in skeletal muscle, where it plays a role in producing energy within muscle cells. Mutations in the AMPD1 gene disrupt the function of AMP deaminase and impair the muscle cells' ability to produce energy. This lack of energy can lead to myalgia or other muscle problems associated with AMP deaminase deficiency.

    The three types of AMP deaminase deficiency are known as the inherited type, acquired type, and coincidental inherited type.

    Individuals with the inherited type have a mutation in both copies of the AMPD1 gene in each cell. Most people are asymptomatic, meaning they have no symptoms. Some people with AMP deaminase deficiency experience muscle weakness or pain following exercise.

    The acquired type occurs in people who have decreased levels of AMP deaminase due to the presence of a muscle or joint condition.

    People with the coincidental inherited type have a mutation in both copies of the AMPD1 gene. Additionally, they have a separate joint or muscle disorder. Some individuals experience more severe joint or muscle symptoms related to their disorder if they have AMP deaminase deficiency than do people without this enzyme deficiency. Most, however, do not have any symptoms associated with AMP deaminase deficiency.

    It is not known why most people with this condition do not experience symptoms. Researchers speculate that additional mutations in other genes may be involved.


    Inheritance:  

    This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition..


    Resources:  










    The information in this page is primarily for reference and education. It is not intended to be a substitute for the advice of a physician. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.

    site map about us news privacy legal contact us
    transparent gif
    transparent gif

    Copyright  2005-2010 . The Paliwoda Group, Inc.
    Updated April 23, 2010. All Rights Reserved.


    Genotype Diagnostics™ and the Genotype Diagnostics logo are trademarkes of The Paliwoda Group, Inc. All other trademarks referenced herein are the property of their respective owners. Reference herein to any specific commercial products, processes, or services by trade name, trademark, manufacturer, or otherwise, does not constitute or imply affiliation with, or endorsement by the respective owners. Genotype Diagnostics™ and The Paliwoda Group are not responsible for content published on websites accessible from this site or for content received from third parties.